ViewRay has received federal regulatory clearance to begin commercializing its MRI-based technology to deliver radiation therapy to cancer patients, reports
MedCity News.
The Oakwood, Ohio-based company's imaging device received clearance under the U.S. Food and Drug Administration's 510(k) program for medical devices, according to a list of clearances from the FDA.
Read the full story
here.